Fulgent

$81.80 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Fulgent

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.

Stock Analysis

last close $81.8
1-mo return -7.2%
3-mo return -13%
avg daily vol. 560.4T
52-week high 189.89
52-week low 41.6
market cap. $2.9B
forward pe 11.2
annual div. -
roe 93%
ltg forecast -
dividend yield -
annual rev. $1.0B
inst own. 38.5%
baraka

Subscribe now for daily local and international financial news

Subscribe